Press Release: Surgical Treatment of FAI Following Slipped Capital Femoral Epiphysis
We are pleased to share with you a recent publication in Bone and Joint Research. This publication is entitled "Surgical treatment of femoroacetabular impingement following slipped capital femoral epiphysis".
Please find access to the full-version of the article click here.
Oduwole KO, de SA D, Kay J, Findakli F, Duong A, Simunovic N, Yen YM, Ayeni OR. Surgical treatment of femoroacetabular impingement following slipped capital femoral epiphysis. Bone and Joint Research Aug 2017, 6 (8) 472-480; DOI: 10.1302/2046-3758.68.BJR-2017-0018.R1
Objectives: The purpose of this study was to evaluate the existing literature from 2005 to 2016 reporting on the efficacy of surgical management of patients with femoroacetabular impingement (FAI) secondary to slipped capital femoral epiphysis (SCFE).
Methods: The electronic databases MEDLINE, EMBASE, and PubMed were searched and screened in duplicate. Data such as patient demographics, surgical technique, surgical outcomes and complications were retrieved from eligible studies.
Results: Fifteen eligible level IV studies were included in this review comprising 261 patients (266 hips). Treatment groups included arthroscopic osteochondroplasty, surgical hip dislocation, and traditional open osteotomy. The mean alpha angle corrections were 32.14° (standard deviation (sd) 7.02°), 41.45° (sd 10.5°) and 6.0° (sd 5.21°), for arthroscopy, surgical hip dislocation, and open osteotomy groups, respectively (p < 0.05). Each group demonstrated satisfactory clinical outcomes across their respective scoring systems. Major complication rates were 1.6%, 10.7%, and 6.7%, for arthroscopy, surgical dislocation and osteotomy treatments, respectively.
Conclusion: In the context of SCFE-related FAI, surgical hip dislocation demonstrated improved correction of the alpha angle, albeit at higher complication and revision rates than both arthroscopic and open osteotomy treatments. Further investigation, including high-quality trials with standardised radiological and clinical outcome measures for young patients, is warranted to clarify treatment approaches and safety.